2006 Annual Meeting | Women's Issues in Cerebrovascular Diseases
09:00 AM - 09:45 AM |
The Importance of Gender in Cerebrovascular Diseases
Irene L. Katzan, MD |
|
09:45 AM - 10:30 AM |
The Borderland of Stroke and Headaches
Gretchen E. Tietjen, MD |
|
10:30 AM - 10:45 AM |
Break
|
|
10:45 AM - 11:30 AM |
Hormones and Hypercoaguability
Cheryl Bushnell, MD, MHS |
|
11:30 AM - 12:15 PM |
Extending the Differential Diagnosis: Unusual Causes
Cathy A. Sila, MD, FAAN |
|
12:15 PM - 12:45 PM |
Questions and Answers
|
Cathy A. Sila, MD, FAAN | Dr. Sila has nothing to disclose. |
Cheryl Bushnell, MD, MHS | Dr. Bushnell has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ZZ Biotech. The institution of Dr. Bushnell has received research support from PCORI. The institution of Dr. Bushnell has received research support from AHRQ. The institution of Dr. Bushnell has received research support from NIH/NINDS. Dr. Bushnell has received intellectual property interests from a discovery or technology relating to health care. Dr. Bushnell has received publishing royalties from a publication relating to health care. |
Irene L. Katzan, MD | Dr. Katzan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring . The institution of Dr. Katzan has received research support from TEVA Pharmaceuticals. |
Gretchen E. Tietjen, MD | Dr. Tietjen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Tietjen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CME Outfitters. An immediate family member of Dr. Tietjen has stock in Johnson & Johnson. |